Sponsored by
This article discusses the effects of releasing ongoing data from clinical trials on the trials themselves. Obviously it helps the trial if the data is good and hurts the trial if the data is bad. What the article doesn't discuss is the effect on the patients. If patients knew which trials were better than others, they would only go to the better trials. Maybe the worse trials should shut down and reformulate in a better way. Our patient navigation program is one way to find the better trials. We have over 700 patients in our registry and we see what treatments they are doing (including trials) and the outcomes. We help guide the patients to the better treatments.